Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Virginia

University of Virginia in Charlottesville, Virginia, United States is listed as a site for 1,075 registered clinical trials, 298 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,075
Ongoing 298

This page covers the site record University of Virginia in Charlottesville, Virginia, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of Virginia, also sponsors trials.

Get the University of Virginia report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,075 trials counted.

  • Phase 1 85 trials
  • Phase 1/2 52 trials
  • Phase 2 162 trials
  • Phase 2/3 20 trials
  • Phase 3 184 trials
  • Phase 4 38 trials
  • Not applicable 343 trials
  • Observational 185 trials
  • Expanded access 6 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 299 trials
  • Completed 542 trials
  • Terminated 129 trials
  • Other 105 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access)

Top of scale: 82

1994: 1 trials (Phase 3 1) 1995: 1 trials (Phase 3 1) 1997: 2 trials (Phase 3 1, Phase 1 1) 1998: 2 trials (Not applicable 1, Phase 1/2 1) 1999: 2 trials (Observational 1, Not applicable 1) 2000: 7 trials (Observational 1, Not applicable 4, Phase 3 1, Phase 2 1) 2001: 3 trials (Observational 2, Phase 1 1) 2002: 7 trials (Observational 1, Phase 4 1, Phase 3 1, Phase 2 4) 2003: 8 trials (Observational 3, Not applicable 1, Phase 3 1, Phase 2/3 2, Phase 1/2 1) 2004: 11 trials (Observational 2, Not applicable 5, Phase 3 2, Phase 2 1, Phase 1/2 1) 2005: 25 trials (Observational 3, Not applicable 6, Phase 3 8, Phase 2/3 1, Phase 2 5, Phase 1/2 1, Phase 1 1) 2006: 27 trials (Observational 4, Not applicable 9, Phase 4 2, Phase 3 8, Phase 2 2, Phase 1/2 1, Phase 1 1) 2007: 22 trials (Not applicable 8, Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 1/2 2, Phase 1 4) 2008: 24 trials (Observational 4, Not applicable 5, Phase 4 2, Phase 3 3, Phase 2/3 1, Phase 2 5, Phase 1/2 3, Phase 1 1) 2009: 26 trials (Observational 1, Not applicable 5, Phase 4 2, Phase 3 6, Phase 2/3 1, Phase 2 9, Phase 1 2) 2010: 27 trials (Observational 2, Not applicable 8, Phase 4 2, Phase 3 7, Phase 2 6, Phase 1/2 2) 2011: 36 trials (Observational 7, Not applicable 9, Phase 4 1, Phase 3 4, Phase 2/3 1, Phase 2 9, Phase 1 5) 2012: 46 trials (Other 1, Observational 8, Not applicable 18, Phase 4 2, Phase 3 7, Phase 2 7, Phase 1 3) 2013: 51 trials (Observational 7, Not applicable 16, Phase 4 2, Phase 3 12, Phase 2/3 2, Phase 2 8, Phase 1/2 1, Phase 1 3) 2014: 37 trials (Observational 10, Not applicable 12, Phase 4 1, Phase 3 4, Phase 2 5, Phase 1/2 4, Phase 1 1) 2015: 41 trials (Observational 12, Not applicable 13, Phase 3 8, Phase 2 6, Phase 1/2 1, Phase 1 1) 2016: 53 trials (Observational 13, Not applicable 14, Phase 4 3, Phase 3 10, Phase 2 5, Phase 1/2 3, Phase 1 5) 2017: 67 trials (Observational 12, Not applicable 22, Phase 4 1, Phase 3 8, Phase 2 16, Phase 1/2 4, Phase 1 4) 2018: 60 trials (Observational 6, Not applicable 28, Phase 4 1, Phase 3 12, Phase 2 4, Phase 1/2 6, Phase 1 3) 2019: 82 trials (Observational 15, Not applicable 29, Phase 4 2, Phase 3 8, Phase 2/3 1, Phase 2 12, Phase 1/2 4, Phase 1 11) 2020: 63 trials (Observational 10, Not applicable 25, Phase 4 1, Phase 3 8, Phase 2/3 1, Phase 2 8, Phase 1/2 2, Phase 1 8) 2021: 67 trials (Observational 17, Not applicable 21, Phase 4 1, Phase 3 15, Phase 2/3 1, Phase 2 9, Phase 1 3) 2022: 69 trials (Observational 9, Not applicable 15, Phase 4 5, Phase 3 9, Phase 2/3 4, Phase 2 14, Phase 1/2 6, Phase 1 7) 2023: 54 trials (Observational 11, Not applicable 22, Phase 4 2, Phase 3 12, Phase 2 2, Phase 1/2 2, Phase 1 3) 2024: 61 trials (Observational 10, Not applicable 19, Phase 4 1, Phase 3 7, Phase 2/3 3, Phase 2 11, Phase 1/2 4, Phase 1 6) 2025: 50 trials (Observational 12, Not applicable 10, Phase 4 5, Phase 3 8, Phase 2/3 1, Phase 2 7, Phase 1/2 2, Phase 1 5)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 34
2025 50
2024 61
2023 54
2022 69
2021 67
2020 63
2019 82
2018 60
2017 67

Showing 10 of 32 years.

Start your 14-day trial Email me all 32 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 3 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,075 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 284 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 541 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF